Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study

Clinical trial NCT04789174 · COMPLETED

Trial details

NCT number: NCT04789174
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Excessive Daytime Sleepiness Obstructive Sleep Apnea Impaired Cognitive Function

Start date: 2021-05-17
Primary completion: 2022-09-19
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.